SCHEMBL18673154

SCHEMBL18673154

C=C/C=C(\C=C)C(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21325907 0.88 LMNA (0.37)
SCHEMBL25598851 0.87
SCHEMBL26414903 0.79 LMNA (0.36)
SCHEMBL18672981 0.77
SCHEMBL17269589 0.77 ALDH1A1 (0.39)
SCHEMBL26289547 0.77
SCHEMBL14161192 0.77 ALDH1A1 (0.39)
SCHEMBL19017541 0.77 LMNA (0.37)
SCHEMBL17804050 0.75 ALDH1A1 (0.32)
SCHEMBL8344137 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9624161-B2 Estrogen receptor ligands and methods of use thereof GTX, INC. (US) 2017-04-18 US disclosed
US-9604910-B2 Composition of 5-nitrobenzoate derivatives as anti-metastatic agent that inhibits tumor cell-induced platelet aggregation CHANG GUNG UNIVERSITY (TW) 2017-03-28 US disclosed